Keywords: BTG, Varisolve, Varicose veins, Ph III

Positive data for BTG’s Varisolve

Article | 30 January 2012

Print This

UK specialist health care firm BTG (LSE: BGC) has announced the successful outcome of VANISH-2, the first of two US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in